# The Effect Of Oral Ibandronate In Male Osteoporosis

> **NCT00397839** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 135 (actual)

## Conditions studied

- Male Osteoporosis

## Interventions

- **DRUG:** Ibandronate
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00397839
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2009-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00397839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00397839, "The Effect Of Oral Ibandronate In Male Osteoporosis". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00397839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*